Document is current
Any future updates will be listed below
-
Authors
Jelicic, Jelena
Juul-Jensen, Karen
Bukumiric, Zoran
Runason Simonsen, Mikkel
Kragh Jørgensen, Rasmus Rask
Roost Clausen, Michael
Ludvigsen Al-Mashhadi, Ahmed
Schou Pedersen, Robert
Bjørn Poulsen, Christian
Ortved Gang, Anne
Brown, Peter
El-Galaly, Tarec Christoffer
Stauffer Larsen, Thomas
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 17 December 2024
First Online: 31 December 2024
Declarations
:
: JJ has received travel support from AstraZeneca and Roche. PB has served on advisory boards for Roche, Abbvie, and SERB. TSL has served on advisory boards/consultancy for Roche, Novartis, Gilead, and BMS. TSL received a research Grant from Genentech and travel support from Roche. Other authors have no relevant financial or non-financial interests to disclose.
: This study was performed in accordance with the principles of the Declaration of Helsinki. The Advisory Board for Clinical Quality Development Program (RKKP) (project number 21/27006) has granted approval for conducting this registry-based study, ensuring total anonymity of patients. Further details can be found in the Declaration on passing personal data covered by § 10, a subsection of the Data Protection Act, 1 and 2’, . Therefore, informed consent from patients was not obtained.
Free to read: This content has been made available to all.
